Entero Therapeutics Shares Rise 5% Before Transitioning to GridAI
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Source: NASDAQ.COM
Company Name Change: Entero Therapeutics, Inc. will rebrand as GridAI Technologies Corp. and change its ticker to GRDX, effective December 1, 2025, following its acquisition of GRID AI Corp.
Strategic Shift: The rebranding reflects a strategic pivot from Entero's focus on gastrointestinal diseases to AI-driven energy infrastructure, specifically software for managing distributed energy resources.
Market Reaction: The announcement led to a 5.28% increase in stock price, with heavier-than-usual trading volume as investors responded to the company's new direction.
Stock Performance: Entero's stock has a 52-week range of approximately $1.20 to $4.10, indicating fluctuations in its market value prior to the announcement.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
